Gunhild von Amsberg

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

Robert J. Motzer, Camillo Porta, Masatoshi Eto et al. · Journal of Clinical Oncology · 2024 · 158 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC)

Sonja Bergmann, Anja Coym, Leonie Ott et al. · OncoImmunology · 2020 · 85 citations · Full text

Medicine, Clinical Sciences, Oncology +17

In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells

Amin El‐Heliebi, Claudia Hille, Navya Laxman et al. · Clinical Chemistry · 2018 · 80 citations · Full text

Medicine, Molecular Medicine, Oncology +17

The marine triterpene glycoside frondoside <scp>A</scp> exhibits activity <i>in vitro</i> and <i>in vivo</i> in prostate cancer

Sergey A. Dyshlovoy, Ekaterina S. Menchinskaya, Simone Venz et al. · International Journal of Cancer · 2015 · 71 citations · Full text

Pharmacy, Pharmacology, Apoptosis +14

Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization

Sergey A. Dyshlovoy, Jessica Hauschild, Kerstin Amann et al. · Oncotarget · 2015 · 70 citations · Full text

Life Sciences, Oncology, Pharmacology +17